Breast cancer is the most frequently diagnosed neoplastic disease in women around
menopause often leading to a significant reduction of these women's ability to function …

Significant advances have been made in the diagnosis and treatment of female breast
cancer, resulting in a decline in incidence and a global improvement in clinical outcome …

Aim Several prognostic histological features have been established in female breast cancer
(BC), but it is unknown whether these can be extrapolated to male BC patients. The aim of …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Background Male breast cancer accounts for less than 1% of all breast cancers, yet males
have a worse prognosis than females with breast cancer. Methods Using the 1988–2003 …

Studies concerning adjuvant systemic therapy and prognosis in male breast carcinoma
(MBC) are limited. We aimed to evaluate outcome of the changing practices of adjuvant …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …

Breast cancer in men is rare, but its incidence is increasing, in keeping with the aging
population. The majority of breast cancers in men are estrogen receptor positive. There is a …

Male breast cancer is an uncommon condition. It often occurs in settings in which there is an
imbalance between androgens and oestrogens. Genetics plays an important role, as many …

Methods Using data obtained by the Surveillance, Epidemiology, and End Results (SEER)
program from 2010-2012, a retrospective, population-based cohort study was conducted to …